BIO|MASTER.CSP Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 152 participants.
Also called NCT06620237
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 152 participants
- Sponsor
- Registry
-
NCT06620237
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Belgium, France, Netherlands, New Zealand
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06620237. Non-randomized; no masking; primary purpose treatment. Start 2024-10-04 (actual); primary completion 2026-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BIO|MASTER.CSP Study
- Condition
- Cardiac Pacing, Artificial
- Condition
- Cardiac Pacemaker, Artificial
- Condition
- Cardiac Resynchronization Therapy Devices
- Condition
- Bradycardia
- Condition
- Conduction Disorder
- Condition
- Conduction Defect, Cardiac
- Condition
- Heart Failure
- Intervention (Device)
- Implantation of the Solia CSP S pacing lead for LBBAP
- Lead sponsor
- Biotronik SE & Co. KG
Record details
- Record id
cardio:ct-nct06620237- Content hash
2233fa13f477b9c59d78dfa51c3192d91080f3082c4f5c88a9b5908765a2e7cd